Department of Surgery, Austin Health, University of Melbourne, Melbourne, Vic., Australia.
Division of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic., Australia.
BJU Int. 2018 May;121 Suppl 3:40-47. doi: 10.1111/bju.14059. Epub 2017 Dec 21.
To describe our technique, illustrated with images and videos, of robot-assisted partial nephrectomy (RAPN) for challenging renal tumours.
A study of 249 patients who underwent RAPN in multiple institutions was performed. Patients were identified using prospective RAPN databases. Complex renal lesion were defined as those with a RENAL nephrometry score ≥10. Data were analysed and differences among groups examined.
A total of 31 (12.4%) RAPNs were performed for complex renal tumours. The median (interquartile range [IQR]) patient age was 57 (50.5-70.5) years and 21 patients (67.7%) were men. The median (IQR) American Society of Anesthesiologists score was 2 (2-3). The median (IQR) operating time was 200 (50-265) min, warm ischaemia time was 23 (18.5-29) min, and estimated blood loss was 200 (50-265) mL. There were no intra-operative complications. Two patients (6.4%) had postoperative complications. One patient (3.2%) had a positive surgical margin. The median (IQR) length of stay was 3.5 (3-5) days and the median (IQR) follow-up was 12.5 (7-24) months. There were no recurrences. RAPN resulted in statistically significant changes in renal function 3 months after RAPN compared with preoperative renal function (P < 0.001).
Our results showed that RAPN was a safe approach for selected patients with complex renal tumours and may facilitate tumour resection and renorrhaphy for challenging cases, offering a minimally invasive surgical option for patients who may otherwise require open surgery.
通过图片和视频描述我们在多中心开展的机器人辅助部分肾切除术(RAPN)治疗复杂肾肿瘤的技术。
对多家医疗机构开展的 249 例行 RAPN 患者进行了研究。通过前瞻性 RAPN 数据库识别患者。复杂肾病变定义为 RENAL 肾肿瘤评分≥10 的患者。分析数据并检查组间差异。
共 31 例(12.4%)RAPN 用于治疗复杂肾肿瘤。患者年龄中位数(四分位距 [IQR])为 57 岁(50.5-70.5),21 例(67.7%)为男性。美国麻醉医师协会评分中位数(IQR)为 2 分(2-3 分)。手术时间中位数(IQR)为 200 分钟(50-265 分钟),热缺血时间中位数(IQR)为 23 分钟(18.5-29 分钟),估计失血量为 200 毫升(50-265 毫升)。无术中并发症。2 例(6.4%)术后发生并发症。1 例(3.2%)患者切缘阳性。中位住院时间(IQR)为 3.5 天(3-5 天),中位随访时间(IQR)为 12.5 个月(7-24 个月)。无复发。RAPN 后 3 个月与术前肾功能相比,肾功能有统计学显著变化(P<0.001)。
我们的研究结果表明,RAPN 是治疗复杂肾肿瘤患者的一种安全方法,可为挑战性病例提供肿瘤切除和肾缝合,为可能需要开放性手术的患者提供微创外科选择。